Experts and patient advocates to discuss growing concerns around blood glucose test strip accuracy

Published on September 7, 2013 at 4:24 AM · No Comments

The Diabetes Hands Foundation announced today that it will send diabetes advocate Bennet Dunlap to participate on a panel September 9, 2013 aiming to address the growing concerns around blood glucose test strip accuracy. Representatives from the U.S. Food and Drug Administration (FDA), clinical experts, research scientists, device manufactures, and patient advocates will meet to identify potential solutions to this serious health threat to adults and children living with diabetes. The meeting will be hosted and facilitated by the Diabetes Technology Society and will take place at the Hyatt Regency Bethesda, in Bethesda, Maryland from 8:30 a.m. to 5 p.m.  Dunlap, who has type 2 diabetes and is the father of two children with type 1 diabetes, will represent the patient perspective on a panel at 3:15 p.m. EDT.

"Like any parent, the safety of my children is my top priority. Millions of people rely on blood glucose test strips every day to stay safe and healthy. It is critical that the FDA holds all manufacturers accountable to the accuracy standards currently in place," said Dunlap. "I'm committed to working with the FDA, Congress and the rest of the diabetes community to ensure all patients with diabetes have access to the tools they need to make educated, informed and accurate treatment decisions."

Dunlap is an active leader in the Diabetes Hands Foundation's Diabetes Advocates program, a group of more than 120 patient champions dedicated to improving the lives of people living with diabetes. He recently launched the awareness campaign StripSafely (, a grassroots movement to educate fellow caregivers, patients and the public about the risk inaccurate glucose test strip readings pose to patients living with diabetes.  Action taken (dosing of insulin, etc.) based on an inaccurate meter reading can lead to a serious hypoglycemic event or even death. The campaign was launched after the FDA confirmed that a number of blood glucose monitoring systems fail to meet accuracy standards after initial approval and introduction into the marketplace.

As a part of the StripSafely effort, Dunlap is working with bloggers and other members of the diabetes community to spread the word about the accuracy issue and engage policymakers to ensure glucose monitors meet minimum accuracy requirements. Since June, participants have sent letters to Congress and more than 3,400 tweets have been issued under the StripSafely hashtag (#StripSafely), garnering attention from patients, industry, and leaders in Washington.

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment